This image is not available for purchase in your country.

Tigecycline molecule, MRSA antibiotic

Tigecycline molecule, MRSA antibiotic

A624/0183

Rights Managed

This image is not available for purchase in your country.

Please contact your Account Manager if you have any query.

Credit

DR TIM EVANS / SCIENCE PHOTO LIBRARY DR TIM EVANS / SCIENCE PHOTO LIBRARY

Caption

Tigecycline molecule. Computer model of a molecule of the MRSA antibiotic drug tigecycline (brand name Tygacil, chemical formula C29.H39.N5.O8). Atoms (tubes) are colour-coded: carbon (green), hydrogen (grey), nitrogen (purple) and oxygen (orange). The drug has been developed to treat drug-resistant bacterial infections including, but not restricted to, methicillin-resistant Staphylococcus aureus (MRSA) bacterial infections. These infections kill many people because the bacteria have developed a resistance to normal antibiotic drugs. Tigecycline was developed by the Wyeth pharmaceutical company, and medical trials started in 2004.

Release details

Model release not required. Property release not required.

 {{ i.shot_duration ? i.shot_duration + ' ' : '' }}{{ i.shot_uhd ? '4K ' : i.hires ? 'HD ' : '' }}{{ i.spl_number }} R{{ i.license }}

  • Add to board
  • Similar {{ mediaType(i) }}